The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia

  1. Xargay-Torrent, S.
  2. López-Guerra, M.
  3. Rosich, L.
  4. Montraveta, A.
  5. Roldán, J.
  6. Rodríguez, V.
  7. Villamor, N.
  8. Aymerich, M.
  9. Lagisetti, C.
  10. Webb, T.R.
  11. López-Otín, C.
  12. Campo, E.
  13. Colomer, D.
Journal:
Oncotarget

ISSN: 1949-2553

Year of publication: 2015

Volume: 6

Issue: 26

Pages: 22734-22749

Type: Article

DOI: 10.18632/ONCOTARGET.4212 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals